The Evolutionary Venomics Lab (EVL) has published landmark research on the spectacled cobra (Naja naja), establishing that despite striking visible differences in colour, markings, and venom composition, the snake forms a single, genetically connected population across mainland India. The findings carry significant implications for anti-venom development in a country where snakebites claim an estimated 58,000 lives annually.

What the Research Found

Researchers at the EVL sequenced nuclear and mitochondrial genetic markers from nearly 100 snakes sampled across the major biogeographical zones of the Indian subcontinent. The results revealed no evidence of deep genetic subdivision within mainland India — a condition scientists describe as a panmictic population, meaning the species interbreeds freely across its range despite geographic barriers such as rivers, mountains, and deserts.

'Across mainland India, the spectacled cobra appears to be largely one connected genetic population. Despite all the visible variation in colour, marking, ecology, and venom, the genetic data did not support the presence of multiple deeply separated species,' said Kartik Sunagar, associate professor at EVL and a lead researcher on the project.

African Origins, Not Asian

The study also overturns a long-held assumption about the cobra's migration history. Earlier theories suggested Naja naja moved from Asia to Africa. The EVL research concludes the reverse: the genus Naja originated in Africa and dispersed into South Asia during the Miocene epoch — between 23 and 5.3 million years ago — travelling through the Middle East. The species subsequently moved from India to Sri Lanka when sea levels were lower, creating a genetically distinct island population.

The Sri Lankan N. naja, the research notes, is genetically differentiated from its mainland counterpart — a distinction that matters for targeted anti-venom formulation.

Why Genetic Uniformity Matters for Anti-Venom

The spectacled cobra is one of India's 'big four' snakes — the quartet responsible for the overwhelming majority of snakebite fatalities in the country. Its near-countrywide distribution and variable venom composition had previously raised the possibility that different regional populations might require different anti-venoms.

The confirmation of genetic uniformity across the mainland simplifies that picture. 'If different populations have different venoms, evolutionary histories, or levels of relatedness, the knowledge can influence how we think of anti-venom, conservation and snakebite biology,' Sunagar explained.

Notably, in 2024, the EVL developed a synthetic anti-venom — part of a broader effort to reduce the number of anti-venom variants that need to be stocked at hospitals and clinics across India.

Broader Scientific Significance

The research paper, published by the EVL, describes N. naja as 'among the most iconic and clinically significant species' yet notes that 'its evolutionary history, phylogenetic diversity, and biogeographical origins remain poorly understood.' This study begins to fill that gap systematically.

Sunagar contextualised the stakes: 'When a species is spread across a vast area, rivers, mountains, deserts, climate, or sea-level changes can separate populations. Over thousands or millions of years, these isolated populations may evolve independently. Eventually, what we once called one species may turn out to be several.' The fact that this has not happened with mainland N. naja is itself a significant scientific result.

With snakebite mortality remaining a critical public health challenge in India, further genetic and venom-composition mapping of the spectacled cobra is expected to directly inform the next generation of anti-venom therapies.